Application of Supercritical Carbon Dioxide for the Preparation of Drug-Cyclodextrin Inclusion Compounds

被引:1
|
作者
T. Van Hees
V. Barillaro
G. Piel
P. Bertholet
S. De Hassonville
B. Evrard
L. Delattre
机构
来源
Journal of inclusion phenomena and macrocyclic chemistry | 2002年 / 44卷
关键词
cyclodextrins; inclusion complexes; miconazole; piroxicam; supercritical CO;
D O I
暂无
中图分类号
学科分类号
摘要
Inclusion complexes of drugs into cyclodextrins (CDs) can be obtained at the solid state by means of supercritical dioxide (SCCO2). A successful inclusion with a yield >98.5% has been achieved with piroxicam and β-CD. The temperature and the time of exposure to SCCO2 have a significant effect on the inclusion yield while the pressure has a negative effect. However, there is a strong interaction between temperature and pressure and this interaction has a positive influence. The molar ratio piroxicam-β-CD and the addition of ternary alkaline agents were also found to be significant factors. The dissolution rate of the complexes formed using SCCO2 was found to be significantly higher than that of the physical mixture. Inclusion complexes have also been obtained with miconazole treating mixtures of miconazole, CDs and citric acid by SCCO2. This new technique of inclusion of poorly soluble drugs into CDs allows the preparation of solid complexes without using organic solvents and thus without residues.
引用
收藏
页码:271 / 274
页数:3
相关论文
共 50 条
  • [1] Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds
    Van Hees, T
    Barillaro, V
    Piel, G
    Bertholet, P
    De Hassonville, SH
    Evrard, B
    Delattre, L
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2002, 44 (1-4) : 271 - 274
  • [2] Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-β-Cyclodextrin Inclusion Compound
    Thierry Van Hees
    Geraldine Piel
    Brigitte Evrard
    Xavier Otte
    Leopold Thunus
    Luc Delattre
    Pharmaceutical Research, 1999, 16 : 1864 - 1870
  • [3] Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound
    Van Hees, T
    Piel, G
    Evrard, B
    Otte, X
    Thunus, L
    Delattre, L
    PHARMACEUTICAL RESEARCH, 1999, 16 (12) : 1864 - 1870
  • [4] Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques
    Ali Al-Marzouqi
    Baboucarr Jobe
    Giovanna Corti
    Marzia Cirri
    Paola Mura
    Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2007, 57 : 223 - 231
  • [5] Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques
    Al-Marzouqi, Ali
    Jobe, Baboucarr
    Corti, Giovanna
    Cirri, Marzia
    Mura, Paola
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2007, 57 (1-4) : 223 - 231
  • [6] Preparation of inclusion complex of piroxicam with cyclodextrin by using supercritical carbon dioxide
    Sauceau, Martial
    Rodier, Elisabeth
    Fages, Jacques
    JOURNAL OF SUPERCRITICAL FLUIDS, 2008, 47 (02): : 326 - 332
  • [7] Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques
    Al-Marzouqi, Ali H.
    Elwy, Hanan M.
    Shehadi, Ihsan
    Adem, Abdu
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (02) : 227 - 233
  • [8] Preparation of borneol–methyl-β-cyclodextrin inclusion complex by supercritical carbon dioxide processing
    Jun He
    Wenjing Li
    Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2009, 65 : 249 - 256
  • [9] Preparation of borneol-methyl-β-cyclodextrin inclusion complex by supercritical carbon dioxide processing
    He, Jun
    Li, Wenjing
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2009, 65 (3-4) : 249 - 256
  • [10] Preparation and stability of a chamomile ointment containing a supercritical carbon dioxide chamomile extract/β-cyclodextrin inclusion complex
    Waleczek, KJ
    Hempel, B
    Schmidt, PC
    STP PHARMA SCIENCES, 2002, 12 (05): : 329 - 333